BMB541: Principles of the Development of Pharmaceuticals
The Study Board for Science
Teaching language: Danish or English depending on the teacher
EKA: N200020112, N200020102
Assessment: Second examiner: None, Second examiner: Internal
Grading: Pass/Fail, 7-point grading scale
Offered in: Odense
Offered in: Autumn
Level: Bachelor
STADS ID (UVA): N200020101
ECTS value: 5
Date of Approval: 31-03-2025
Duration: 1 semester
Version: Archive
Comment
Entry requirements
this course can only be selected if:
- It is a mandatory part of your degree program.
- It is specifically recommended as an elective ECTS course in the suggested study plan.
- It is part of a defined transition for a course you have not yet completed.
Academic preconditions
The course runs in close dialogue with the concurrent course BMB549 and builds on the fundamental molecular and cell biological knowledge acquired there.
Course introduction
The aim of the course is to enable students to understand and engage with the principles of pharmaceutical development, including the use of modern biotechnology in the treatment of human diseases, as well as to comprehend the role of a biomedical scientist. Furthermore, the course helps students contextualize later courses with a higher level of theoretical abstraction within a broader framework.
Expected learning outcome
To achieve the course's objectives, the learning goals for the course are that the student demonstrates the ability to:
- Understand the overarching principles of developing new drugs up to approval for clinical use.
- Gain knowledge of the process involved in identifying new drugs.
- Understand the general process of how biological drugs are produced.
- Comprehend the design and evaluation of a clinical study.
- Understand the molecular basis of selected diseases.
- Understand the principles for identifying development strategies for drugs, based on knowledge of the molecular basis of diseases.
- Gain knowledge of the effects of selected drugs on the organism.
Content
The course includes the following main academic areas:
- The history of drug development
- Processes and phases in pharmaceutical research
- Drug interaction with targets or receptors
- Pharmacokinetics and pharmacodynamics
- Toxicological testing of drugs
- Processes and phases in drug development
- Clinical studies: design and statistical evaluation
- Production of biological drugs
- Molecular understanding of diseases as a prerequisite for drug development
- Information retrieval related to task solving
- Molecular basis for selected diseases
- Antibodies as drugs
Literature
Wiley Blackwell: Drugs; From Discovery to Approval, af Rick Ng, 3rd edition.
Kopier af uddrag fra bøger og tidsskrifter, disse udleveres under kurset.
See itslearning for syllabus lists and additional literature references.
Examination regulations
Exam element a)
Timing
Autumn
Tests
New
EKA
N200020112
Assessment
Second examiner: None
Grading
Pass/Fail
Identification
Full name and SDU username
Language
Normally, the same as teaching language
Examination aids
To be announced during the course
ECTS value
2.5
Exam element b)
Timing
January
Tests
Written exam
EKA
N200020102
Assessment
Second examiner: Internal
Grading
7-point grading scale
Identification
Student Identification Card - Name
Language
Normally, the same as teaching language
Duration
2 hours
Examination aids
The exam is with limited aids. Only the following aids are allowed:
- Built-in standard calculators in Windows/macOS/Linux.
- Maple, Mathematica, Mathcad, MATLAB, GeoGebra Apps, R (including R-Studio), CAS TI-Nspire, MS Excel, and LibreOffice Calc are allowed. WordMat is permitted but not recommended. Use of WordMat is at your own risk, and no support will be provided for breakdowns or other errors caused by the program.
Internet is not allowed. However, you may access the course page in itslearning to open system "DE–Digital Exam" and complete any tests within the system.
ECTS value
2.5
Additional information
The exam is conducted as a multiple choice test.
Indicative number of lessons
Teaching Method
Planned lessons:
Total number of planned lessons: 40
Hereof:
Common lessons in classroom/auditorium: 22
Team lessons in classroom: 18
Common lessons consist of presentations where students are broadly informed about various aspects of pharmaceutical research, focusing on topics relevant to biomedical students. Additionally, they will receive guidance on skill acquisition and information retrieval.
During team lessons, which include computer simulations and problem-based learning, students work on various assignments, thereby gaining competencies in the central aspects of the course.
Other planned teaching activities:
Students are expected to work independently with the textbook, examples, and exercises therein. They are also expected to spend a significant amount of time working on assignments related to the group sessions and reviewing for the written exam.
Activities include:
- Reading the curriculum
- Watching videos covering parts of the curriculum
- Solving theoretical exercises
- Preparing group assignments
- Working with computer simulations, e-tests, etc.
Teacher responsible
| Name | Department | |
|---|---|---|
| Jonas Heilskov Graversen | jgraversen@health.sdu.dk | Cancer & Inflammationsforskning - Inflammation |
Additional teachers
| Name | Department | City | |
|---|---|---|---|
| Peter Zvara | pzvara@health.sdu.dk | Klinisk Institut | |
| Tore B. Stage | tstage@health.sdu.dk | Institut for Sundhedstjenesteforskning |
Timetable
Administrative Unit
Team at Registration
Offered in
Recommended course of study
Transition rules
Transitional arrangements describe how a course replaces another course when changes are made to the course of study.
If a transitional arrangement has been made for a course, it will be stated in the list.
See transitional arrangements for all courses at the Faculty of Science.